Overview
Location
China
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 20, 2025 | Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington's Disease Treatment | SHANGHAI, Oct. 20, 2025 /PRNewswire/ -- The research team led by Dr. Yuejun Chen, founder of UniXell Biotech, published online an article titled "3D-Cultured Human Medium Spiny Neurons Achieve Functional Integration into Huntingtin Dis... |
| May 23, 2025 | UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson's disease, in its Phase 1 study | SHANGHAI, May 23, 2025 /PRNewswire/ -- Shanghai UniXell Biotechnology Co., Ltd. (UniXell Biotech), a biotech company dedicated to innovative cell therapies, announced the successful first administration of its proprietary Parkinson's diseas... |
| UniXell Biotechnology | “跃 上海生物生物生物生物生物有生物公 上海官跃” |
Reviews 0
FAQ about 上海跃赛生物科技有限公司
What has the press written about 上海跃赛生物科技有限公司?
Parsers VC has collected 4 articles mentioning 上海跃赛生物科技有限公司, among them “Groundbreaking Study in the Journal of Clinical Investigation Advances Cell Therapy for Huntington's Disease Treatment” (Oct 20, 2025) and “UniXell Biotechnology announces the first patient dosed with UX-DA001, an investigational autologous iPSC based cell therapy for the treatment of Parkinson's...” (May 23, 2025).
Is 上海跃赛生物科技有限公司 still active?
Yes, 上海跃赛生物科技有限公司 is active; its latest activity on Parsers VC dates from Mar 13, 2026.